Eighty years of research on islet amyloidosis in Uppsala

References

• Gellerstedt N. Die elektive, insuläre (Para-)Amyloidose der Bauchspeicheldrüse. Zugleich ein Beitrag zur Kenntnis der “senilen Amyloidose”. Beitr Path Anat. 1938;101:1–13.
   Google Scholar
• Ehrlich JC, Ratner IM. Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and nondiabetic individuals. Am J Path. 1961;38:49–59.
   PubMed Web of Science ®Google Scholar
• Warren S, LeCompte PM, Legg MA. The pathology of diabetes mellitus. 4th ed. Philadelphia: Lea & Febiger; 1966.
   Google Scholar
• Cohen AS, Calkins E. Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature. 1959;183:1202–3.
   PubMed Web of Science ®Google Scholar
• Eanes ED, Glenner GG. X-ray diffraction studies on amyloid filaments. J Histochem Cytochem. 1968;16:673–7.
   PubMed Web of Science ®Google Scholar
• Glenner GG, Eanes ED, Bladen HA, Linke RP, Termine JD. β-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem. 1974;22:1141–58.
   PubMed Web of Science ®Google Scholar
• Sipe JD, Benson MD, Ikeda S, Merlini G, Saraiva MJ, Westermark P. Updated nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidoses. Amyloid. 2014;21:221–4.
   PubMed Web of Science ®Google Scholar
• Eisenberg D, Jucker M. The amyloid state of protein in human diseases. Cell. 2012;148:1188–203.
   PubMed Web of Science ®Google Scholar
• Westermark P. Mast cells in the islets of Langerhans in insular amyloidosis. Virchows Arch Path Anat. 1971;354:17–23.
   PubMedGoogle Scholar
• Westermark P. Quantitative studies of amyloid in the islets of Langerhans. Upsala J Med Sci. 1972;77:91–4.
   PubMed Web of Science ®Google Scholar
• Jurgens CA, Toukatly MN, Fligner CL, Udayasankar J, Subramanian SL, Zraika S, et al. β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. Am J Pathol. 2011;178:2632–40.
   PubMed Web of Science ®Google Scholar
• Rochet J-C, Lansbury PTJ. Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol. 2000;10:60–8.
   PubMed Web of Science ®Google Scholar
• Oskarsson ME, Paulsson JF, Schultz SW, Ingelsson M, Westermark P, Westermark GT. In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer’s disease. Am J Pathol. 2015;185:834–46.
   PubMed Web of Science ®Google Scholar
• Westermark P. Fine structure of islets of Langerhans in insular amyloidosis. Virchows Arch A Pathol Pathol Anat. 1973;359:1–18.
   PubMedGoogle Scholar
• Westermark P, Wernstedt C, Wilander E, Sletten K. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun. 1986;140:827–31.
   PubMed Web of Science ®Google Scholar
• Westermark P, Andersson A, Westermark GT. Islet amyloid polypeptide, islet amyloid and diabetes mellitus. Physiol Rev. 2011;91:795–826.
   PubMed Web of Science ®Google Scholar
• Westermark P, Grimelius L. The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Path Microbiol Scand A. 1973;81:291–300.
   PubMedGoogle Scholar
• Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res. 1988;9:151–9.
   PubMedGoogle Scholar
• Law E, Lu S, Kieffer TJ, Warnock GL, Ao Z, Woo M, et al. Differences between amyloid toxicity in alpha and beta cells in human and mouse islets and the role of caspase-3. Diabetologia. 2010;53:1415–27.
   Google Scholar
• Lundgren G, Andersson A, Borg H, Buschard K, Groth CG, Gunnarsson R, et al. Structural and functional integrity of isolated human islets of langerhans maintained in tissue culture for 1-3 weeks. Transplant Proc. 1977;9:237–40.
   PubMedGoogle Scholar
• Korsgren O, Jansson L, Eizirik D, Andersson A. Functional and morphological differentiation of fetal porcine islet-like cell clusters after transplantation into nude mice. Diabetologia. 1991;34:379–86.
   PubMed Web of Science ®Google Scholar
• Sandler S, Andersson A, Schnell A, Mellgren A, Tollemar J, Borg H, et al. Tissue culture of human fetal pancreas. Development and function of B-cells in vitro and transplantation of explants to nude mice. Diabetes. 1985;34:1113–19.
   PubMed Web of Science ®Google Scholar
• Jansson L, Eizirik DL, Pipeleers DG, Borg LA, Hellerström C, Andersson A. Impairment of glucose-induced insulin secretion in human pancreatic islets transplanted into diabetic nude mice. J Clin Invest. 1995;96:721–6.
   PubMed Web of Science ®Google Scholar
• Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerström C, Andersson A. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. Proc Natl Acad Sci USA. 1994;91:9253–6.
   PubMed Web of Science ®Google Scholar
• Westermark P, Eizirik DL, Pipeleers DG, Hellerström C, Andersson A. Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia. 1995;38:543–9.
   PubMed Web of Science ®Google Scholar
• Westermark GT, Westermark P, Nordin A, Törnelius E, Andersson A. Formation of amyloid in human pancreatic islets transplanted to the liver and spleen of nude mice. Ups J Med Sci. 2003;108:193–204.
   PubMed Web of Science ®Google Scholar
• Westermark GT, Westermark P, Eizirik D, Hellerström C, Fox N, Steiner DF, et al. Differences in amyloid deposition in islets of transgenic mice expressing human islet amyloid polypeptide versus human islets implanted into nude mice. Metabolism. 1999;48:448–54.
   PubMed Web of Science ®Google Scholar
• Westermark GT, Westermark P, Berne C, Korsgren O. Widespread amyloid deposition in transplanted human pancreatic islets. N Engl J Med. 2008;359:977–9.
   PubMed Web of Science ®Google Scholar
• Westermark GT, Davalli AM, Secchi A, Folli F, Kin T, Toso C, et al. Further evidence for amyloid deposition in clinical pancreatic islet grafts. Transplantation. 2012;93:219–23.
   PubMedGoogle Scholar
• Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, et al. Five-year follow up after clinical islet transplantation. Diabetes. 2005;54:2060–9.
   PubMed Web of Science ®Google Scholar
• Westermark P, Andersson A, Westermark GT. Is aggregated IAPP a cause of beta-cell failure in transplanted human pancreatic islets? Curr Diab Rep. 2005;5:184–8.
   PubMedGoogle Scholar
• Potter KJ, Abedini A, Marek P, Klimek AM, Butterworth S, Driscoll M, et al. Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci USA. 2010;107:4305–10.
   PubMed Web of Science ®Google Scholar
• Glenner GG, Wong CW. Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984;120:885–90.
   PubMed Web of Science ®Google Scholar
• Glenner GG, Wong CW. Alzheimer’s disease and Down’s syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun. 1984;122:1131–5.
   PubMed Web of Science ®Google Scholar
• Masters C, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA. 1985;82:4245–9.
   PubMed Web of Science ®Google Scholar
• O’Nuallian B, Williams AD, Westermark P, Wetzel R. Seeding specificity in amyloid growth induced by heterologous fibrils. J Biol Chem. 2004;279:17490–9.
   PubMedGoogle Scholar